CASL Abstract Submission Guidelines
ABSTRACT SUBMISSION FOR CLM IS OPEN!
We are now accepting abstracts for CLM 2026! Share your latest research or innovative ideas for your chance to be part of the Joint CDDW™-CLM Conference 2026 — the premiere meeting for all members of the Canadian gastroenterology and hepatology communities.
Don’t miss this opportunity to showcase your work. Submit your abstract today!
Important Dates
Abstract Submission Extended Deadline: Wednesday, October 15, 2025
Notification Date: Early December 2025
Conference / Abstract Themes
Submission Topics:
Autoimmune Liver Disease – Biomedical, Translational & Basic Science
Autoimmune Liver Disease – Clinical Science, Epidemiology & Public Health
ALD – Biomedical, Translational & Basic Science
ALD – Clinical Science, Epidemiology & Public Health
MASLD/MASH – Biomedical, Translational & Basic Science
MASLD/MASH – Clinical Science, Epidemiology & Public Health
Other liver disease – Biomedical, Translational & Basic Science
Other liver disease – Clinical Science, Epidemiology & Public Health
Viral Hepatitis – Biomedical, Translational & Basic Science
Viral Hepatitis – Clinical Science, Epidemiology & Public Health
Please note that the Abstract Review Committee reserves the right to re-categorize any abstract as deemed appropriate.
Process
Abstracts will undergo a peer-review process. The Abstract Review Committee will assess each abstract based on its adherence to format, scientific merit, and alignment with the overall conference themes. Authors of abstracts selected for presentation will be contacted via email by early December and invited to present either a poster or oral presentation at the meeting.
All selected abstracts will be made available to the Conference participants in electronic format, on the conference website.
Additionally, abstracts that are confirmed for presentation at early December will be published in the Canadian Liver Journal.
Abstract Format
Title:
Background:
Purpose:
Method:
Result(s):
Conclusion(s):
Mitigation of Bias
- Presentations must present a balanced view of the available therapeutic options. Brand names of pharmaceuticals and trade names of medical devices should not be used in the title or body of the abstract. Use of generic names will contribute to impartiality.
- The Abstract Review Committee reserves the right to change the abstract if they feel that the use of a trade name may be mistaken for commercial propaganda and may replace proprietary names with generic names. In addition, logos or images of products that include a trade name or representing a commercial interest will be removed prior to presentation and publication.
Disclosure of Conflicts of Interest
The presenting authors of abstracts selected for oral presentation will be required to complete and submit a Disclosure of Conflicts of Interest form after they are invited to present. Disclosures are due on or before the RSVP deadline.
Abstract Form Submission
Please use the official online abstract submission form only.
- Abstracts must be submitted electronically using the official online submission form.
- Abstracts must identify the presenting author along with email address and phone number.
- Please use standard abbreviations. Place special or unusual abbreviations in parenthesis after the full word when it appears for the first time.
- Errors, misspellings, and incorrect abbreviations will not be corrected.
- Minimize the use of charts as this detail is not used to evaluate the merit of your abstract.
- Abstracts must not exceed 3000 characters (excluding the abstract heading).
- An individual may submit more than one abstract. One official online submission is required for each abstract.
- There is no fee to submit abstract(s).
- Edits to submitted abstracts may be made up to the submission deadline. Instructions for making edits can be found on the online abstract submission form.
- All submitters must identify whether their abstract has been previously submitted and/or published, but encore abstracts will be considered for presentation.
Canadian Liver Meeting Young Investigator Travel Grants
Qualifying first authors of abstracts submitted to the Canadian Liver Meeting may apply for a Young Investigator Award. Grant application is completed by ticking a box within the abstract submission system. Awards are given to presenters of oral or poster presentations that are to be presented at the Canadian Liver Meeting at the CDDW™-CLM 2026.
I. Purpose
The Young Investigator Awards recognize outstanding young investigators’ research accomplishments and looks to promote their travel to attend the Canadian Liver Meeting to present their research.
II. Award
For those attending onsite, the award consists of:
· one complimentary conference registration,
· two nights’ accommodation at the conference hotel, and
· reimbursement of travel expenses (economy flight, train ticket or mileage) up to 800.
Reimbursement will be made after the meeting by bank transfer.
III. Eligibility
Candidates must have submitted an abstract as a first author that has been accepted for oral or poster presentation at the CDDW™-CLM 2026.
Candidates must be a CASL member. Members to CASL is complimentary for trainees/students. Further information can be found here.
Candidates must be a medical, nursing, nursing practitioner or graduate student, resident or fellow (clinical or post-doc researcher).
IV. Application Process
Award application will be based on merit & criteria. Please make sure you meet the requirements.
V. Selection Process
Abstracts will be revised and scored by the Canadian Liver Meeting Scientific Review Committee. Award applicants will be notified of their abstract submission and award application in December 8, 2025.
Presentation at the Meeting
- A number of abstracts will be selected for oral presentation; indicate on the submission form whether you are interested in being considered for an oral presentation.
- If an abstract is accepted for oral presentation, the presenter(s) agree(s) to register for the conference and pay the appropriate conference registration fee. Presenters will receive a notification regarding their abstract prior to the Early Bird registration deadline in order to benefit from the reduced rate.
- The Conference will not cover expenses of those presenting posters, or giving an oral presentation based on an abstract submission. Abstract submitters who may be eligible to receive such funding will be contacted separately regarding these opportunities.
- Further details regarding presentation formatting will be sent to accepted abstract presenters at a later date.
Copyright Permission
By submitting abstracts to the conference, submitters authorize, upon acceptance, the permission to reproduce their abstract in the conference proceedings to be published in the Canadian Liver Journal and on the conference website.
English 
French